Medtronic offers insulin pumps in Indian market
EPP News Bureau Mumbai Medtronic offers Model 508 series insulin
pumps help insulin-dependent patients improve their blood sugar control. In
fact, maintaining near-normal blood sugar levels using predictable, rapid-acting
insulin, delivered precisely and on command by an insulin pump can help patients
reduce their risk of diabetes-related complications, including blindness, kidney
failure, amputation, impotence and heart disease.
An A1c measurement reflects patients’ average blood sugar
control over a two-to-three month period. Patients maintaining target A1c levels
using Model 508 series insulin pumps can live longer, healthier lives. Clinician
and patient acceptance of insulin pump therapy has been very favourable in India.
‘‘There is a growing body of evidence supporting insulin pump therapy for improved
glycaemic control,’’ states S K Wangnoo, MD, a leading diabetologist in Delhi
Once patients begin using an insulin pump, 97 per cent remain
on pump therapy. Results from a randomised, controlled, crossover trial in five
countries throughout Europe recently demonstrated that pump users achieved significantly
better overall quality of life compared to those using injection therapy. The
pump users had less diabetes-related worry, higher treatment satisfaction and
improved flexibility in terms of eating habits, lifestyle and sleep patterns.
Moreover, 100 per cent of the study’s pump users recommended
insulin pump therapy, while only 63 percent of the injection users recommended
traditional syringe therapy to treat diabetes. In fact, pump therapy is associated
with less risk of hypoglycaemia (low blood sugar), which is a common concern
among many diabetes patients. Clinical studies have proven that insulin pumps
can reduce severe hypoglycaemia by up to 85 percent and mild-to-moderate hypoglycaemia
by up to 60 percent, compared to injection therapy.
Patients using Medtronic’s Model 508 series insulin pumps
can customise basal insulin delivery using three different basal patterns, each
with up to 48 different basal rates. This customisation allows for changing
lifestyle needs, such as exercise, sick days and during sleep, a time when fluctuating
blood sugar levels cause concern for many patients.
Additional features include a low volume alert, an optional
vibrate mode, and a child block feature to restrict programming for children
with curious fingers. Model 508 series insulin pumps hold a large 3 ml reservoir
and store up to 90 days of data, which can be downloaded to a personal computer
to help patients and their physicians review insulin requirements for improved
diabetes management. Model 508 and Model 508R insulin pumps share the same pump
features. Model 508 insulin pumps are sold with a four-year warranty and include
a remote control device for more discreet insulin delivery.